N-Allyl-vanillamid | 91133-76-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: N-Allyl-vanillamid
• 英文别名: 4-hydroxy-3-methoxy-N-prop-2-enylbenzamide
• CAS: 91133-76-5
• 化学式: C₁₁H₁₃NO₃
• 分子量: 207.229
• InChiKey: GYOFCUBQADGCLV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Pain reliever and method of use
  申请人：——

  公开号：US20010011083A1

  公开（公告）日：2001-08-02

  A composition containing capsicium extract together with other ingredients to neutralize the discomfort resulting from the application of capsicium extract to the skin enabling treatment of many types of discomforts, including arthritis pain, neuropathy, post surgical scarring, hemorrhoid pain and itching, and pruritis without the discomfort normally associated with the topical application of capsicium extract.

  一种含有蒴果提取物和其他成分的组合物，可中和因在皮肤上涂抹蒴果提取物而产生的不适感，从而治疗多种不适症状，包括关节炎疼痛、神经病变、手术后瘢痕、痔疮疼痛和瘙痒，而不会产生通常因局部涂抹蒴果提取物而产生的不适感。
• Pharmaceutical compositions for the treatment of pruritus
  申请人：Burbaum J. Jonathan

  公开号：US20050272772A1

  公开（公告）日：2005-12-08

  Composition comprising: a carrier; a first active ingredient comprising capsaicin, a capsaicin analog, another vanilloid receptor agonist or mixtures thereof; and at least one second active ingredient that functions as a topical anesthetic to cause localized numbness to induced skin irritation. Technique for treating the symptoms of pruritus comprising the step of applying a composition comprising a carrier, a first active ingredient comprising capsaicin, a capsaicin analog, another vanilloid receptor agonist or mixtures thereof, and at least one second active ingredient that functions as a topical anesthetic, to cause localized numbness to induced skin irritations.

  组合物，包括：载体；第一种活性成分，包括辣椒素、辣椒素类似物、另一种茸毛受体激动剂或其混合物；以及至少一种第二种活性成分，其作用是局部麻醉，以引起局部麻木，从而诱发皮肤过敏。治疗皮肤瘙痒症状的技术，包括以下步骤：施用一种组合物，该组合物包含载体、第一种活性成分（包括辣椒素、辣椒素类似物、另一种类香草素受体激动剂或其混合物）和至少一种用作局部麻醉剂的第二种活性成分，以对诱发的皮肤刺激造成局部麻木。
• PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PRURITUS
  申请人：Burbaum, Jonathan J.

  公开号：EP1763349A2

  公开（公告）日：2007-03-21
• Composition to Mitigate Spikes in Blood Sugar
  申请人：Panacea Scientific, Inc.

  公开号：US20170007591A1

  公开（公告）日：2017-01-12

  Compositions comprising therapeutically effective amounts of quercetin, myricetin and chlorogenic acid are improved by the addition of one or multiple additional components, for mitigating blood sugar spikes in general and for treating diabetes specifically. Certain other additives produce additional benefits.
• US5854291A
  申请人：——

  公开号：US5854291A

  公开（公告）日：1998-12-29